NCT06885164

Brief Summary

Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death. Heart failure is treated with medicine which relieves symptoms and slows down the disease progression. This medical treatment needs routine adjustment, but in many cases, this adjustment is not done timely, which results in life treating conditions where the patients need acute hospitalization. Remote health monitoring of HF patients has the potential to ensure timely adjustment. However, only sensors placed inside the blood vessels of the lung, have been shown effective. The disadvantage is that the placement of the sensor requires surgery. This makes the method costly and poses a risk for the patient. The aim of the current project is to develop a small intelligent patch, which can measure the heart's function from the outside of the body. The method will be low-cost, simple to use and will not pose a risk to the patient.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jun 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jun 2025Jan 2027

First Submitted

Initial submission to the registry

September 10, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

March 20, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

June 11, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

1.3 years

First QC Date

September 10, 2024

Last Update Submit

January 15, 2026

Conditions

Keywords

heart failureremote monitoringcardiac mechanics

Outcome Measures

Primary Outcomes (1)

  • Rate of Heart Failure Related Hospitalization

    It will during the study be noted if an enrolled participant is hospitalized due to an alteration in heart failure condition.

    Within 60 days of enrollment

Secondary Outcomes (3)

  • Rate and direction of Adjustement in Medical Therapy

    During the 30 days

  • Differences in Echocardiographic extracted strain pre and post study period

    Day 1 and day 30

  • Score of Patient Experience

    At day 30

Study Arms (1)

Heart Failure Participants

The included participants will be heart failure patients that are hospitalized or visits a heart failure clinic. The participants should be in NYHA Class II or higher and 18-90 years old. The participant should wear the sensor for 30 days, and it will measure every hour for the 30 days. Moreover, the participant should undergo echocardiography and answer questionnaire at enrollment day and at the last day of the study (day 30).

Other: Continuous monitroing

Interventions

Continuous monitoring for 30 days with a small combined SCG and 1-lead ECG sensor

Heart Failure Participants

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants will be obtained from Aalborg University Hospital or Herlev-Gentofte Hospital in Denmark that are hospitalized or visits the heart failure clinic due to their heart failure.

You may qualify if:

  • NYHA Class II or higher
  • years old

You may not qualify if:

  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids, or other drugs
  • Mechanical heart valves
  • In dialysis
  • Not possible to obtain clinical echocardiography of sufficient quality
  • Lack of ability to coorperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aalborg University Hospital

Aalborg, Denmark, 9000, Denmark

RECRUITING

Copenhagen University Hospital Herlev

Herlev, Denmark, 2730, Denmark

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Central Study Contacts

Samuel Schmidt, MSc, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 10, 2024

First Posted

March 20, 2025

Study Start

June 11, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations